185 related articles for article (PubMed ID: 8087420)
1. Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels.
Kristipati R; Nádasdi L; Tarczy-Hornoch K; Lau K; Miljanich GP; Ramachandran J; Bell JR
Mol Cell Neurosci; 1994 Jun; 5(3):219-28. PubMed ID: 8087420
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel subtypes in rat brain: biochemical characterization of the high-affinity receptors for omega-conopeptides SNX-230 (synthetic MVIIC), SNX-183 (SVIB), and SNX-111 (MVIIA).
Woppmann A; Ramachandran J; Miljanich GP
Mol Cell Neurosci; 1994 Aug; 5(4):350-7. PubMed ID: 7804605
[TBL] [Abstract][Full Text] [Related]
3. Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium-channel antagonist, SNX-230 (omega-conopeptide MVIIC).
Gohil K; Bell JR; Ramachandran J; Miljanich GP
Brain Res; 1994 Aug; 653(1-2):258-66. PubMed ID: 7982059
[TBL] [Abstract][Full Text] [Related]
4. Toxityping rat brain calcium channels with omega-toxins from spider and cone snail venoms.
Adams ME; Myers RA; Imperial JS; Olivera BM
Biochemistry; 1993 Nov; 32(47):12566-70. PubMed ID: 8251474
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of omega-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels.
Nielsen KJ; Adams D; Thomas L; Bond T; Alewood PF; Craik DJ; Lewis RJ
J Mol Biol; 1999 Jun; 289(5):1405-21. PubMed ID: 10373375
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity analysis of a Conus peptide blocker of N-type neuronal calcium channels.
Nadasdi L; Yamashiro D; Chung D; Tarczy-Hornoch K; Adriaenssens P; Ramachandran J
Biochemistry; 1995 Jun; 34(25):8076-81. PubMed ID: 7794920
[TBL] [Abstract][Full Text] [Related]
7. SNX-325, a novel calcium antagonist from the spider Segestria florentina.
Newcomb R; Palma A; Fox J; Gaur S; Lau K; Chung D; Cong R; Bell JR; Horne B; Nadasdi L
Biochemistry; 1995 Jul; 34(26):8341-7. PubMed ID: 7541240
[TBL] [Abstract][Full Text] [Related]
8. Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.
Bowersox SS; Miljanich GP; Sugiura Y; Li C; Nadasdi L; Hoffman BB; Ramachandran J; Ko CP
J Pharmacol Exp Ther; 1995 Apr; 273(1):248-56. PubMed ID: 7714772
[TBL] [Abstract][Full Text] [Related]
9. Different omega-conotoxins mark the development of Swiss Webster mouse cortex suggesting N-type voltage sensitive calcium channel subtypes.
Abbott JR; Litzinger MJ
Int J Dev Neurosci; 1994 Feb; 12(1):43-7. PubMed ID: 8010158
[TBL] [Abstract][Full Text] [Related]
10. Irreversible and reversible blockade of IMR32 calcium channel currents by synthetic MVIIA and iodinated MVIIC omega-conopeptides.
Fox JA
Pflugers Arch; 1995 Apr; 429(6):873-5. PubMed ID: 7603842
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel antagonist peptides define several components of transmitter release in the hippocampus.
Gaur S; Newcomb R; Rivnay B; Bell JR; Yamashiro D; Ramachandran J; Miljanich GP
Neuropharmacology; 1994 Oct; 33(10):1211-9. PubMed ID: 7862257
[TBL] [Abstract][Full Text] [Related]
12. Analogies and differences between omega-conotoxins MVIIC and MVIID: binding sites and functions in bovine chromaffin cells.
Gandía L; Lara B; Imperial JS; Villarroya M; Albillos A; Maroto R; García AG; Olivera BM
Pflugers Arch; 1997 Dec; 435(1):55-64. PubMed ID: 9359903
[TBL] [Abstract][Full Text] [Related]
13. Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers.
Wang YX; Bezprozvannaya S; Bowersox SS; Nadasdi L; Miljanich G; Mezo G; Silva D; Tarczy-Hornoch K; Luther RR
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):159-68. PubMed ID: 9521489
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of [125I]omega-conotoxin MVIIA binding to rat neocortical membranes.
Stoehr SJ; Dooley DJ
Neurosci Lett; 1993 Oct; 161(1):113-6. PubMed ID: 8255536
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the omega-conotoxin-binding molecule in rat brain synaptosomes and cultured neurons.
Marqueze B; Martin-Moutot N; Levêque C; Couraud F
Mol Pharmacol; 1988 Aug; 34(2):87-90. PubMed ID: 2457794
[TBL] [Abstract][Full Text] [Related]
16. Novel omega-conopeptides reduced field potential amplitudes in the rat hippocampal slice.
Fox JA
Neurosci Lett; 1994 Jan; 165(1-2):157-60. PubMed ID: 8015718
[TBL] [Abstract][Full Text] [Related]
17. Effects of chirality at Tyr13 on the structure-activity relationships of omega-conotoxins from Conus magus.
Nielsen KJ; Adams DA; Alewood PF; Lewis RJ; Thomas L; Schroeder T; Craik DJ
Biochemistry; 1999 May; 38(21):6741-51. PubMed ID: 10346894
[TBL] [Abstract][Full Text] [Related]
18. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom.
Olivera BM; Cruz LJ; de Santos V; LeCheminant GW; Griffin D; Zeikus R; McIntosh JM; Galyean R; Varga J; Gray WR
Biochemistry; 1987 Apr; 26(8):2086-90. PubMed ID: 2441741
[TBL] [Abstract][Full Text] [Related]
19. Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes.
Yasuda O; Morimoto S; Chen Y; Jiang B; Kimura T; Sakakibara S; Koh E; Fukuo K; Kitano S; Ogihara T
Biochem Biophys Res Commun; 1993 Jul; 194(2):587-94. PubMed ID: 8393668
[TBL] [Abstract][Full Text] [Related]
20. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.
Bowersox SS; Gadbois T; Singh T; Pettus M; Wang YX; Luther RR
J Pharmacol Exp Ther; 1996 Dec; 279(3):1243-9. PubMed ID: 8968347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]